These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 826261

  • 1. [Study on the antibacterial activity of penicillins and cephalosporines in urine (author's transl)].
    Shah PM, Schirmer KP, Helm EB, Stille W.
    Arzneimittelforschung; 1976; 26(9):1636-8. PubMed ID: 826261
    [Abstract] [Full Text] [Related]

  • 2. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
    Shah PM, Zwischenbrugger H, Stille W.
    MMW Munch Med Wochenschr; 1976 Nov 05; 118(45):1469-72. PubMed ID: 825763
    [Abstract] [Full Text] [Related]

  • 3. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM, Gebicka K, Borowski J.
    J Hyg Epidemiol Microbiol Immunol; 1973 Nov 05; 17(2):129-40. PubMed ID: 4199760
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amoxicillin: in vitro susceptibility of "blood culture strains" of gram-negative bacilli and comparisons with penicillin G ampicillin, and carbenicillin.
    Finland M, McGowan JE, Garner C, Wilcox C.
    J Infect Dis; 1974 Jun 05; 129(0):suppl:S132-8. PubMed ID: 4210005
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP, Briedis DJ, Robson HG, Conterato JP.
    Antimicrob Agents Chemother; 1979 Mar 05; 15(3):346-50. PubMed ID: 111609
    [Abstract] [Full Text] [Related]

  • 7. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
    Deguchi K, Oda S, Sato Y, Ikeda Y, Nakamura T.
    Jpn J Antibiot; 1975 Dec 05; 28(6):785-94. PubMed ID: 1104913
    [Abstract] [Full Text] [Related]

  • 8. [In vitro and in vivo antibacterial activity of cephapirin (author's transl)].
    Mitsuhashi S, Yaginuma S, Ono H, Kurashige S.
    Jpn J Antibiot; 1974 Apr 05; 27(2):152-6. PubMed ID: 4211466
    [No Abstract] [Full Text] [Related]

  • 9. Comparative in vitro activity of amoxicillin and ampicillin against bacteria isolated from ill children.
    Marks MI.
    Curr Ther Res Clin Exp; 1974 Oct 05; 16(10):1137-44. PubMed ID: 4154827
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Comparison of in vitro bacteriostatic effect of five betalactamins against Pseudomonas aeruginosa (author's transl)].
    Lesage D, Delisle-Mizon F, Denis C, Vergez P, Daguet GL.
    Pathol Biol (Paris); 1982 Jun 05; 30(6):440-3. PubMed ID: 6213917
    [Abstract] [Full Text] [Related]

  • 14. Microbiological activity of cefazedone as compared to cefazolin and cephalothin.
    Knothe H.
    Arzneimittelforschung; 1979 Jun 05; 29(2a):378-81. PubMed ID: 39575
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The effect of gentamicin and other antibiotics on the pathogenic germs in urinary tract infections (author's transl)].
    Schmid W.
    Med Klin; 1973 Dec 14; 68(50):1652-6. PubMed ID: 4205807
    [No Abstract] [Full Text] [Related]

  • 20. [Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)].
    Shah PM, Stille W.
    Arzneimittelforschung; 1978 Dec 14; 28(9):1539-41. PubMed ID: 383106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.